Copy Number Variation in CHRNA7 Gene in Migraine and Gene Expression
NCT04912752 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2021-06-03
Summary
Migraine is a common and possible hereditary disease. Copy number variation (CNV) is a phenomenon in which parts of the genome are repeated and the number of repeats in the genome varies between individuals in the human population.The CHRNA7 gene has a major role in the neuropsychiatric phenotypes observed in patients. The 15q13.3 gain/loss variation in this gene may be associated with migraine.
Conditions
Interventions
- GENETIC
-
Migraine CNV
Copy number variation effect on migraine disease
Sponsors & Collaborators
-
University of Gaziantep
lead OTHER
Principal Investigators
-
Mehmet Fatih Özaltun, MD · Assist
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-04-05
- Primary Completion
- 2020-12-10
- Completion
- 2021-01-02
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Plasma Levels of CGRP and Expression of Specific microRNAs in Blood Cells of Episodic and Chronic Migraine Subjects
NCT04473976 ·Status: COMPLETED
-
Prevalence and Determinants of Migraine Among Headache Patients
NCT07038499 ·Status: NOT_YET_RECRUITING
-
Treatments of Migraine with Triptans in Individuals with Elevated Cardiovascular Risk and in Pregnant Women
NCT05854992 ·Status: COMPLETED
-
Transcriptomic and Biochemical Changes During a Migraine Attack
NCT02468622 ·Status: COMPLETED
-
Glyceryl-Trinitrate-Induced Headache in Patients With Familial Hemiplegic Migraine
NCT00541736 ·Status: COMPLETED ·Phase: NA
-
Prevalence of Chronic Abdominal Pain in Migraneurs
NCT05086562 ·Status: UNKNOWN
-
Role of Specific microRNAs in Cluster Headache
NCT06503328 ·Status: RECRUITING
-
A Study to Compare Blood Levels of Different Dosage Formulations of the Study Medicine That Is a CGRP Receptor Antagonist in Healthy Adults
NCT07261371 ·Status: COMPLETED ·Phase: PHASE1
-
Manageable Environmental Factors in Migraine
NCT06304675 ·Status: COMPLETED
-
Glyceryl-Trinitrate-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2
NCT00257985 ·Status: COMPLETED ·Phase: NA
-
Retrospective Study on the Use of CEFALY® Device During Migraine Attacks
NCT02616978 ·Status: COMPLETED
-
Rate , Predictors and Outcome of Chronic Migraine
NCT05079659 ·Status: UNKNOWN
-
The Role of CGRPand Nociceptin in Migraine
NCT00155129 ·Status: UNKNOWN
-
Suppressive Functions of Regulatory T Cells in Migraine
NCT07067112 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Calcitonin Gene-related Peptide in Familial Hemiplegic Migraine (FHM) and Migraine With Aura (MA)
NCT00687947 ·Status: COMPLETED ·Phase: NA
-
Effect of Sumatriptan on Levcromakalim-Induced Symptoms in Individuals With Migraine
NCT05211050 ·Status: COMPLETED ·Phase: NA
-
Monoclonal CGRP Antibodies for Migraine Prevention - a Nationwide Real Life Study
NCT05281770 ·Status: RECRUITING
-
Central Sensitization and Neuropathic Pain in Cervicogenic Headache
NCT07292181 ·Status: COMPLETED
-
MicroRNA Profile and Erenumab Treatment
NCT04659226 ·Status: COMPLETED ·Phase: NA
-
miR-155 Expression in Episodic and Chronic Migraine
NCT05891808 ·Status: UNKNOWN
-
Cabergoline as a Preventive Treatment for Chronic Migraine
NCT05525611 ·Status: COMPLETED ·Phase: NA
-
Study to Test an Approved Product in the Early Treatment of Migraine (0462-066)
NCT00095004 ·Status: COMPLETED ·Phase: PHASE3
-
Pain Processing in Adults With Migraines
NCT02748577 ·Status: COMPLETED ·Phase: NA
-
A Study of LY2951742 (Galcanezumab) in Japanese Participants With Migraine
NCT02959190 ·Status: COMPLETED ·Phase: PHASE3
-
Flunarizine Versus Topiramate for Chronic Migraine Prophylaxis
NCT02639598 ·Status: COMPLETED ·Phase: PHASE4